Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Trond Velde Bogsrud"'
Autor:
Trond Velde Bogsrud, Ola Engelsen, Thuy Thu Thi Lu, Andreas Stensvold, Derek R. Johnson, Brian J. Burkett, Ayse Tuba Kendi, Mukesh K. Pandey, Rune Sundset, Jolanta M. Durski
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Background The main objective is to discuss why treatment of non-prostate cancers with [177Lu]Lu-PSMA-radioligand achieved only low tumor dose in most published cases, despite high uptake on PSMA PET. We use a patient with renal cell carcino
Externí odkaz:
https://doaj.org/article/c7a558f85543439ab71692c0bdc3c94e
Autor:
Trine Husby, Håkon Johansen, Trond Velde Bogsrud, Kari Vekseth Hustad, Birte Veslemøy Evensen, Ronald Boellaard, Guro F. Giskeødegård, Unn-Merete Fagerli, Live Eikenes
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Purpose The aim of this prospective study was to investigate the prognostic value of metabolic tumor volume (MTV) and apparent diffusion coefficient (ADC) from baseline FDG PET/MRI compared to established clinical risk factors in terms of pr
Externí odkaz:
https://doaj.org/article/2e5784f3b17b414bb4f4d9f341318fbf
Publikováno v:
Tomography, Vol 8, Iss 3, Pp 1477-1484 (2022)
Background: 18F-fluciclovine is a positron emission tomography (PET) radiotracer approved for the detection of prostate cancer recurrence. No effect of androgen deprivation therapy (ADT) on its performance has been established. Purpose: To study the
Externí odkaz:
https://doaj.org/article/91e0c797123244dc97bdc654e221f4db
Autor:
Lars C. Gormsen, Mikkel H. Vendelbo, Mette Abildgaard Pedersen, Ate Haraldsen, Karin Hjorthaug, Trond Velde Bogsrud, Lars J. Petersen, Karen Juul Jensen, Rasmus Brøndum, Tarec C. El-Galaly
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-8 (2019)
Abstract Background Semi-automated quantitative measurement of metabolic tumor volume (MTV) for prognosis in diffuse large B-Cell lymphoma (DLBCL) has gained considerable interest lately. However, simple tumor volume measures may be inadequate for as
Externí odkaz:
https://doaj.org/article/29e82eb47e464e30aa0e4ad784d018cd
Autor:
Trond Velde Bogsrud, Marita Jacobsen, Jolanta M Durski, Ola Engelsen, Eivind La Puebla Larsen, Olav Inge Håskjold, Miguel Castillejo, Tore Ingolv Bach-Gansmo, Douglas Van Nostrand
Publikováno v:
Thyroid.
Autor:
Marcel, Lindemann, Ana, Oteiza, Montserrat, Martin-Armas, Yngve, Guttormsen, Angel, Moldes-Anaya, Rodrigo, Berzaghi, Trond Velde, Bogsrud, Tore, Bach-Gansmo, Rune, Sundset, Mathias, Kranz
Publikováno v:
European journal of nuclear medicine and molecular imaging.
Glioblastoma multiforme (GBM) is the most common glioma and standard therapies can only slightly prolong the survival. Neo-vascularization is a potential target to image tumor microenvironment, as it defines its brain invasion. We investigate [[[[
Autor:
Marcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, Yngve Guttormsen, Angel Moldes-Anaya, Rodrigo Berzaghi, Trond Velde Bogsrud, Tore Bach-Gansmo, Rune Sundset, Mathias Kranz
Publikováno v:
Lindemann, M, Oteiza, A, Martin-Armas, M, Guttormsen, Y, Moldes-Anaya, A, Berzaghi, R, Bogsrud, T V, Bach-Gansmo, T, Sundset, R & Kranz, M 2023, ' Glioblastoma PET/MRI : kinetic investigation of [ 18 F]rhPSMA-7.3, [ 18 F]FET and [ 18 F]fluciclovine in an orthotopic mouse model of cancer ', European journal of nuclear medicine and molecular imaging, vol. 50, no. 4, pp. 1183-1194 . https://doi.org/10.1007/s00259-022-06040-z
Purpose Glioblastoma multiforme (GBM) is the most common glioma and standard therapies can only slightly prolong the survival. Neo-vascularization is a potential target to image tumor microenvironment, as it defines its brain invasion. We investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695569f55370c5f051c0f08d3aa9e7d1
https://hdl.handle.net/10037/28555
https://hdl.handle.net/10037/28555
Autor:
Fenton Ingram, Lucia Zanoni, Frode Willoch, David M. Schuster, Tore Bach-Gansmo, Stefano Fanti, Heikki Minn, Cristina Nanni, Ephraim Parent Edward, Bital Savir-Baruch, Eugene Teoh, Trond Velde Bogsrud
Publikováno v:
Nanni, C, Zanoni, L, Bach-Gansmo, T, Minn, H, Willoch, F, Bogsrud, T V, Edward, E P, Savir-Baruch, B, Teoh, E, Ingram, F, Fanti, S & Schuster, D M 2020, ' [ 18 F]Fluciclovine PET/CT : joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 ', European journal of nuclear medicine and molecular imaging, vol. 47, no. 3, pp. 579-591 . https://doi.org/10.1007/s00259-019-04614-y
The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [18F]Fluciclovine PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatab
Publikováno v:
Durski, J M, Hruska, C B, Bogsrud, T V, Ryder, M & Johnson, G B 2021, ' 123 I Scan with Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry before 131 I Treatment of Metastatic Thyroid Cancer ', Clinical Nuclear Medicine, vol. 46, no. 3, pp. e151-e153 . https://doi.org/10.1097/RLU.0000000000003464
A previously published model (Atkins) allows for calculation of 131I maximum tolerated activity on the basis of 48-hour whole-body retention of 131I on a pretherapy diagnostic scan. Our practice uses iodine 123I for diagnostic imaging of metastatic t
Autor:
Eirik Malinen, Torbjørn Furre, Morten E. Evensen, J.M. Moan, Trond Velde Bogsrud, Cecilie Delphin Amdal, Torleiv Skjøtskift, Einar Dale
Publikováno v:
Skjøtskift, T, Evensen, M E, Furre, T, Moan, J M, Amdal, C D, Bogsrud, T V, Malinen, E & Dale, E 2018, ' Dose painting for re-irradiation of head and neck cancer ', Acta Oncologica, vol. 57, no. 12, pp. 1693-1699 . https://doi.org/10.1080/0284186X.2018.1512753
Background: For patients with recurrent or second primary disease, re-irradiation can be challenging due to overlap with previously irradiated volumes. Dose painting may be attractive for these patients, as the focus is on delivering maximal dose to